Sign Up to like & get recommendations! 1
Published in 2020 at "Social Psychiatry and Psychiatric Epidemiology"
DOI: 10.1007/s00127-020-01991-w
Abstract: New hospitalizations after first episode psychosis (FEP) may be viewed as an indicator of instability in a psychotic disorder. In the current study we wanted to analyse long term risk for psychosis hospitalizations after FEP.… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Current Diabetes Reports"
DOI: 10.1007/s11892-019-1220-8
Abstract: The prevalence of diabetes is 2–3-fold higher in people with severe mental illness than the general population. There are concerns that antipsychotics increase the risk of diabetes. This review will examine the latest epidemiological studies… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "European Psychiatry"
DOI: 10.1016/j.eurpsy.2017.02.373
Abstract: Introduction Patients with schizophrenia have 3-fold higher mortality from lifestyle diseases, and a long-lasting exposure to antipsychotic medication may contribute to the development of somatic illnesses. Region of Central Jutland was inspired by European initiatives… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Heliyon"
DOI: 10.1016/j.heliyon.2019.e01763
Abstract: Chronic psychotic disorders (CPDs) occur worldwide and cause significant burden including reduced quality of life and functional impairment. Care for CPD includes psychosocial and pharmacologic interventions (i.e. antipsychotic drugs) and ongoing health monitoring. This is… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Psychological Medicine"
DOI: 10.1017/s0033291717000903
Abstract: Background Capturing service users’ perspectives can highlight additional and different concerns to those of clinicians, but there are no up to date, self-report psychometrically sound measures of side effects of antipsychotic medications. Aim To develop… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Psychological Medicine"
DOI: 10.1017/s0033291718001836
Abstract: Abstract Background The effect of antipsychotics medication on cognitive functioning in patients diagnosed with schizophrenia is poorly understood. Some studies of second generation antipsychotics indicated that they improved cognitive functioning while other studies have found… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Psychological Medicine"
DOI: 10.1017/s0033291725101372
Abstract: Abstract Background Antipsychotic (AP) medication in individuals at clinical high risk for psychosis (CHR-P) is not routinely recommended by clinical guidelines but is commonly prescribed. Since little is known about the predictors of AP inception… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "Translational Psychiatry"
DOI: 10.1038/s41398-025-03582-2
Abstract: Approximately 20–30% of patients treated for schizophrenia concomitantly take two or more antipsychotic substances, despite the limited evidence that antipsychotic combination treatment is superior to monotherapy. Positron emission tomography (PET) studies can reveal the relationship… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Issues in Mental Health Nursing"
DOI: 10.1080/01612840.2017.1386744
Abstract: ABSTRACT Individuals with a mental illness are reported to have a reduced life expectancy and a greater risk of being affected by preventable physical illnesses such as cardiovascular disease and Type 2 diabetes. This inquiry… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of child and adolescent psychopharmacology"
DOI: 10.1089/cap.2015.0123
Abstract: OBJECTIVE The purpose of this study was to explore the use of multiple antipsychotic medications in patients with autism spectrum disorder (ASD) by reviewing the longitudinal medication management of 1100 patients consecutively treated for behavioral… read more here.